Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Contract Notice

Automated NAT Assay System

  • First published: 16 November 2021
  • Last modified: 16 November 2021
  • Version: N/A
  • This file may not be fully accessible.

  •  

Information icon

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Information icon
You are viewing an expired notice.

Contents

Summary

OCID:
Published by:
Scottish National Blood Transfusion Service
Authority ID:
AA23764
Publication date:
16 November 2021
Deadline date:
22 December 2021
Notice type:
Contract Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

SNBTS wishes to contract for the provision of an automated NAT assay system, incorporating all equipment, test kits, reagents, relevant controls and calibrators, I.T peripherals, delivery, installation, training and fully comprehensive systems maintenance.

The SNBTS NMRU (National Microbiological Reference Unit) provides confirmatory and screening services for blood borne infections that can be acquired through transfusion and transplantation, in addition the NMRU perform look-back investigations on confirmed positive donors and suspected transfusion transmitted infections (TTIs).

NMRU currently use in-house assimilated assays for HCV, HIV and HBV NAT testing. These are fully validated and have been used within SNBTS for many years. The assays involve two stages; nucleic acid extraction and polymerase chain amplification (PCR).

In addition to the need to replace the current PCR platform (which will involve replacement of current assays) used for HCV, HIV & HBV NAT in NMRU, it is anticipated that the number of HBV NAT assays performed will increase significantly after SaBTO recommend anti-HBc screening for blood donors. Anti-HBc screening will generate a significant number of confirmatory HBV NAT tests and HBV NAT tests associated with lookback investigation on donors confirmed to be anti-HBc reactive. This will increase the NMRU annual workload for HBV NAT tests significantly (100 test cf. 2000-3000 in year 1 of anti-HBc screening, 1000 in year 2 and 500 in subsequent years).

Therefore, a small scale automated platform will be essential for NMRU to cope with the increased volume of HBV NAT testing due to the implementation of anti-HBc screening testing

Full notice text

Contract notice

Section I: Contracting authority

I.1) Name and addresses

Scottish National Blood Transfusion Service

The Jack Copland Centre, 52 Research Avenue, Heriot-Watt Research Park

Edinburgh

EH14 4BE

UK

Telephone: +44 1313145522

E-mail: gordon.dickson@nhs.scot

NUTS: UKM

Internet address(es)

Main address: http://www.scotblood.co.uk/

Address of the buyer profile: https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA12722

I.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge at:

https://www.publictendersscotland.publiccontractsscotland.gov.uk


Additional information can be obtained from the abovementioned address


Tenders or requests to participate must be sent electronically to:

https://www.publictendersscotland.publiccontractsscotland.gov.uk


I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

Automated NAT Assay System

Reference number: NSS212241

II.1.2) Main CPV code

33100000

 

II.1.3) Type of contract

Supplies

II.1.4) Short description

SNBTS wishes to contract for the provision of an automated NAT assay system, incorporating all equipment, test kits, reagents, relevant controls and calibrators, I.T.peripherals, delivery, installation, training and fully comprehensive systems maintenance.

II.1.6) Information about lots

This contract is divided into lots: No

II.2) Description

II.2.2) Additional CPV code(s)

33100000

II.2.3) Place of performance

NUTS code:

UKM75

II.2.4) Description of the procurement

SNBTS wishes to contract for the provision of an automated NAT assay system, incorporating all equipment, test kits, reagents, relevant controls and calibrators, I.T peripherals, delivery, installation, training and fully comprehensive systems maintenance.

The SNBTS NMRU (National Microbiological Reference Unit) provides confirmatory and screening services for blood borne infections that can be acquired through transfusion and transplantation, in addition the NMRU perform look-back investigations on confirmed positive donors and suspected transfusion transmitted infections (TTIs).

NMRU currently use in-house assimilated assays for HCV, HIV and HBV NAT testing. These are fully validated and have been used within SNBTS for many years. The assays involve two stages; nucleic acid extraction and polymerase chain amplification (PCR).

In addition to the need to replace the current PCR platform (which will involve replacement of current assays) used for HCV, HIV & HBV NAT in NMRU, it is anticipated that the number of HBV NAT assays performed will increase significantly after SaBTO recommend anti-HBc screening for blood donors. Anti-HBc screening will generate a significant number of confirmatory HBV NAT tests and HBV NAT tests associated with lookback investigation on donors confirmed to be anti-HBc reactive. This will increase the NMRU annual workload for HBV NAT tests significantly (100 test cf. 2000-3000 in year 1 of anti-HBc screening, 1000 in year 2 and 500 in subsequent years).

Therefore, a small scale automated platform will be essential for NMRU to cope with the increased volume of HBV NAT testing due to the implementation of anti-HBc screening testing

II.2.5) Award criteria

Criteria below:

Quality criterion: Quality / Weighting: 80

Price / Weighting:  20

II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 60

This contract is subject to renewal: Yes

Description of renewals:

The Authority shall be entitled, at its option, to continue this Agreement beyond the Initial Term for three (3) twelve (12) Contract Month periods subject to giving not less than six (6) Contract Months’ notice to the Contractord

II.2.9) Information about the limits on the number of candidates to be invited

II.2.10) Information about variants

Variants will be accepted: No

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section III: Legal, economic, financial and technical information

III.1) Conditions for participation

III.1.2) Economic and financial standing

List and brief description of selection criteria:

As per Section 4B of the SPD Bidders Must provide information on Economic and Financial Standing in the section of the SPD relating to this.

4B (1.71.2) – Last 3 years’ turnover

Insurance Requirements:

4B (1.71.12)

Employer's (Compulsory) Liability: Five Million Pounds Sterling (GBP 5,000,000)

Public Liability: Five Million Pounds Sterling (GBP 5,000,000)

Product Liability: Five Million Pounds Sterling (GBP 5,000,000)


III.1.3) Technical and professional ability

List and brief description of selection criteria:

As per Section 4C (question 1.74.3 - 4C.1.2) of the SPD Bidders Must provide information on Services in the section of the SPD relating to this.

Question Description

Please provide relevant examples of supplies and/or services carried out during the last three years as specified in the Contract Notice:

(Examples from both public and/or private sector customers and clients may be provided)


III.2) Conditions related to the contract

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Open procedure

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

IV.2) Administrative information

IV.2.2) Time limit for receipt of tenders or requests to participate

Date: 22/12/2021

Local time: 12:00

IV.2.4) Languages in which tenders or requests to participate may be submitted

EN

IV.2.7) Conditions for opening of tenders

Date: 22/12/2021

Local time: 12:00

Section VI: Complementary information

VI.1) Information about recurrence

This is a recurrent procurement: No

VI.2) Information about electronic workflows

Electronic ordering will be used

Electronic invoicing will be accepted

VI.3) Additional information

The buyer is using PCS-Tender to conduct this ITT exercise. The Project code is 19959. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343

(SC Ref:671541)

VI.4) Procedures for review

VI.4.1) Review body

Court of Session

Parliament House, Parliament Square

Edinburgh

EH1 1RQ

UK

VI.5) Date of dispatch of this notice

15/11/2021

Coding

Commodity categories

ID Title Parent category
33100000 Medical equipments Medical equipments, pharmaceuticals and personal care products

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
gordon.dickson@nhs.scot
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.